Centre Hospitalier Regional Universitaire De Tours
- Address
- 2 Boulevard Tonnelle, 37044 Tours, France
Dermatology and Immune-Mediated Skin Disease Research
At Centre Hospitalier Regional Universitaire De Tours, clinical trials in skin and connective tissue diseases and immune system diseases focus on conditions such as alopecia areata and atopic dermatitis. These studies are designed to evaluate new treatment options and better understand how to improve symptom control in children, adolescents, and adults.
- Testing targeted therapies for alopecia areata in pediatric patients
- Evaluating treatment effectiveness for atopic dermatitis with added topical care
- Assessing safety and long-term benefit of newer immune-based treatments
This area of research reflects a strong interest in finding more effective and better-tolerated approaches for chronic inflammatory skin conditions.
Pediatric Gastroenterology and Digestive Inflammation
The site also supports trials in digestive system and oral physiological phenomena and immune system processes, with a particular emphasis on Crohn's disease. Research here aims to improve treatment response in children with moderate to severe disease and to expand options for patients who have not responded well to standard therapies.
- Studying a new therapy for pediatric Crohn's disease
- Measuring effectiveness in children with active inflammatory bowel disease
- Evaluating safety and real-world usefulness of advanced immune treatments
These trials highlight the hospital’s role in advancing care for complex childhood digestive disorders.
Pediatric Oncology and Hematology
Clinical research in neoplasms and hemic and lymphatic diseases includes studies for standard risk ALK-positive anaplastic large cell lymphoma. The goal is to improve cure rates and support more effective treatment strategies for children and adolescents with this rare cancer.
- Evaluating treatment effectiveness in ALK-positive anaplastic large cell lymphoma
- Seeking better outcomes for children with a lymphatic malignancy
- Exploring ways to increase long-term disease control
This research area shows a clear commitment to pediatric cancer care and to refining therapies for rare blood-related cancers.
Rare Pediatric Lymphatic Disorders
Another important field at the Hôpital Clocheville department involves female urogenital diseases and pregnancy complications alongside immune-related disease processes, with trials focused on lymphatic malformations associated with PIK3CA mutation. The main purpose is to assess whether targeted treatment can reduce these abnormalities and improve patient outcomes.
- Testing a targeted therapy for PIK3CA-related lymphatic malformations
- Evaluating radiological response as a marker of improvement
- Supporting care for children and adults with rare vascular-lymphatic conditions
These studies contribute to better diagnosis and treatment planning for uncommon disorders that often require specialized expertise.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 35 therapeutic areas and 15 of 752 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 697 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 129 by active trials.
lock +128 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +93 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier Regional Universitaire De Tours
lock Showing 1 of 628 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A 52-Week, Phase 3, Open-Label Extension Study of ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP) | Acadia Pharmaceuticals Inc. | Phase III | Recruiting | May 2026 | — |
IMP list
lock Showing 1 of 752 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Rituximab | 39 | Unknown | 2014-03-24 | 2026-07-20 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.